協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/09/20 | 2,105 | 2,115 | 2,079 | 2,095 | -2 | -0.1% | 1,166,700 |
2018/09/19 | 2,113 | 2,120 | 2,090 | 2,097 | +18 | +0.9% | 1,087,500 |
2018/09/18 | 2,025 | 2,086 | 2,021 | 2,079 | +66 | +3.3% | 970,900 |
2018/09/14 | 2,006 | 2,013 | 1,985 | 2,013 | +26 | +1.3% | 1,511,400 |
2018/09/13 | 2,030 | 2,032 | 1,985 | 1,987 | -19 | -0.9% | 860,300 |
2018/09/12 | 2,014 | 2,016 | 1,991 | 2,006 | -14 | -0.7% | 917,700 |
2018/09/11 | 1,998 | 2,030 | 1,998 | 2,020 | +17 | +0.8% | 1,028,000 |
2018/09/10 | 2,000 | 2,011 | 1,987 | 2,003 | +10 | +0.5% | 1,221,200 |
2018/09/07 | 1,979 | 1,994 | 1,959 | 1,993 | +31 | +1.6% | 1,305,600 |
2018/09/06 | 1,959 | 1,975 | 1,948 | 1,962 | -1 | -0.1% | 656,600 |
2018/09/05 | 1,980 | 1,980 | 1,956 | 1,963 | -20 | -1% | 683,500 |
2018/09/04 | 1,980 | 1,991 | 1,950 | 1,983 | -6 | -0.3% | 774,400 |
2018/09/03 | 1,969 | 1,997 | 1,948 | 1,989 | +19 | +1% | 1,029,600 |
2018/08/31 | 1,923 | 1,972 | 1,920 | 1,970 | +50 | +2.6% | 1,255,200 |
2018/08/30 | 1,974 | 1,976 | 1,919 | 1,920 | -34 | -1.7% | 1,375,900 |
2018/08/29 | 1,948 | 1,967 | 1,940 | 1,954 | +20 | +1% | 915,600 |
2018/08/28 | 1,958 | 1,960 | 1,924 | 1,934 | -19 | -1% | 1,019,100 |
2018/08/27 | 1,935 | 1,957 | 1,927 | 1,953 | +12 | +0.6% | 853,600 |
2018/08/24 | 1,942 | 1,946 | 1,930 | 1,941 | +1 | +0.1% | 1,349,300 |
2018/08/23 | 1,950 | 1,954 | 1,927 | 1,940 | ±0 | ±0% | 898,500 |
2018/08/22 | 1,935 | 1,953 | 1,923 | 1,940 | +11 | +0.6% | 1,111,600 |
2018/08/21 | 1,925 | 1,936 | 1,910 | 1,929 | -12 | -0.6% | 831,200 |
2018/08/20 | 1,966 | 1,968 | 1,930 | 1,941 | -44 | -2.2% | 1,036,400 |
2018/08/17 | 1,995 | 2,012 | 1,976 | 1,985 | +79 | +4.1% | 2,207,000 |
2018/08/16 | 1,951 | 1,960 | 1,894 | 1,906 | -65 | -3.3% | 2,093,700 |
2018/08/15 | 2,011 | 2,020 | 1,953 | 1,971 | -90 | -4.4% | 1,944,400 |
2018/08/14 | 2,060 | 2,067 | 2,047 | 2,061 | +18 | +0.9% | 957,400 |
2018/08/13 | 2,078 | 2,082 | 2,043 | 2,043 | -40 | -1.9% | 839,700 |
2018/08/10 | 2,109 | 2,110 | 2,077 | 2,083 | -23 | -1.1% | 1,044,600 |
2018/08/09 | 2,092 | 2,110 | 2,085 | 2,106 | +6 | +0.3% | 797,800 |
2018/08/08 | 2,130 | 2,130 | 2,099 | 2,100 | -51 | -2.4% | 1,079,000 |
2018/08/07 | 2,156 | 2,160 | 2,141 | 2,151 | -18 | -0.8% | 628,900 |
2018/08/06 | 2,153 | 2,170 | 2,137 | 2,169 | +37 | +1.7% | 1,001,900 |
2018/08/03 | 2,135 | 2,149 | 2,112 | 2,132 | +1 | ±0% | 854,800 |
2018/08/02 | 2,181 | 2,194 | 2,118 | 2,131 | -79 | -3.6% | 1,345,400 |
2018/08/01 | 2,229 | 2,264 | 2,177 | 2,210 | +93 | +4.4% | 1,507,800 |
2018/07/31 | 2,100 | 2,125 | 2,083 | 2,117 | -2 | -0.1% | 995,600 |
2018/07/30 | 2,147 | 2,152 | 2,102 | 2,119 | -49 | -2.3% | 774,200 |
2018/07/27 | 2,149 | 2,170 | 2,134 | 2,168 | +23 | +1.1% | 651,300 |
2018/07/26 | 2,149 | 2,149 | 2,122 | 2,145 | +16 | +0.8% | 1,047,100 |
2018/07/25 | 2,133 | 2,142 | 2,101 | 2,129 | +16 | +0.8% | 1,092,400 |
2018/07/24 | 2,130 | 2,155 | 2,108 | 2,113 | -26 | -1.2% | 1,436,000 |
2018/07/23 | 2,152 | 2,170 | 2,138 | 2,139 | -26 | -1.2% | 1,099,400 |
2018/07/20 | 2,157 | 2,182 | 2,144 | 2,165 | +9 | +0.4% | 1,192,700 |
2018/07/19 | 2,178 | 2,186 | 2,150 | 2,156 | -33 | -1.5% | 828,300 |
2018/07/18 | 2,254 | 2,257 | 2,188 | 2,189 | -54 | -2.4% | 1,008,600 |
2018/07/17 | 2,189 | 2,254 | 2,177 | 2,243 | +43 | +2% | 1,157,600 |
2018/07/13 | 2,180 | 2,217 | 2,166 | 2,200 | +44 | +2% | 1,309,300 |
2018/07/12 | 2,157 | 2,190 | 2,152 | 2,156 | +25 | +1.2% | 856,400 |
2018/07/11 | 2,140 | 2,154 | 2,112 | 2,131 | -18 | -0.8% | 974,300 |
1501~
1550
件表示中 / 3581件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 257,000円 | +11.3% | -5.4% | 2.26% | 19.78倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 214,000円 | +5.7% | +3.9% | 2.68% | 10.65倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 502,900円 | +1.7% | -2.9% | 3.18% | 32.99倍 | 1.73倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 181,500円 | -3.5% | -50.2% | 4.41% | 14.70倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 274,400円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム